[French clinical practice guidelines developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease]
Guideline
OA: hybrid
CC0
⤵ 3 in-corpus citations
AI-generated summary
This Delphi consensus study established 28 practice guidelines for fertility preservation via oocyte vitrification in women with benign gynecological diseases.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVES: To provide clinical practice guidelines about fertility preservation (FP) for women with benign gynecologic disease (BGD) developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease.
METHODS: A steering committee composed of 14 healthcare professionals and a patient representative with lived experience of endometriosis identified 42 potential practices related to FP for BGD. Then 114 key stakeholders including various healthcare professionals (n=108) and patient representatives (n=6) were asked to participate in a modified Delphi process via two online survey rounds from February to September 2020 and a final meeting. Due to the COVID-19 pandemic, this final meeting to reach consensus was held as a videoconference in November 2020.
RESULTS: Survey response of stakeholders was 75 % (86/114) for round 1 and 87 % (75/86) for round 2. Consensus was reached for the recommendations for 28 items, that have been distributed into five general categories: (i) Information to provide to women of reproductive age with a BGD, (ii) Technical aspects of FP for BGD, (iii) Indications for FP in endometriosis, (iv) Indications for FP for non-endometriosis BGD, (v) Indications for FP after a fortuitous diagnosis of an idiopathic diminished ovarian reserve.
CONCLUSION: These guidelines provide some practice advice to help health professionals better inform women about the possibilities of cryopreserving their oocytes prior to the management of a BGD that may affect their ovarian reserve and fertility.
STUDY FUNDING/COMPETING INTEREST(S): The CNGOF (Collège National des Gynécologues Obstétriciens Français) funded the implementation of the Delphi process.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (29)
- Clinical practice. Endometriosis via openalex
- Endometriosis surgery and preservation of fertility, what surgeons should know via openalex
- Fertility preservation in women with endometriosis: speculations are finally over, the time for real data is initiated via openalex
- Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis via openalex
- Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process via openalex
- Oocyte vitrification for fertility preservation in women with endometriosis: an observational study via openalex
- P–454 Oocyte vitrification for fertility preservation in women with benign gynecological disease: French national clinical guidelines with a modified Delphi consensus process via openalex
- Systematic evaluation of endometriosis by transvaginal ultrasound can accurately replace diagnostic laparoscopy, mainly for deep and ovarian endometriosis via openalex
- The Role of Fertility Preservation in Women with Endometriosis: A Systematic Review via openalex
- Transvaginal ethanol sclerotherapy for an endometrioma in 10 steps via openalex
- When more is not better: 10 'don'ts' in endometriosis management. An ETIC * position statement via openalex
- W2795588819 via openalex
- W2799612689 via openalex
- W2806607956 via openalex
- W2897997466 via openalex
- W2904754806 via openalex
- W2976390864 via openalex
- W3105381727 via openalex
- W6727442037 via openalex
- W1892192976 via openalex
- W2047138255 via openalex
- W2083175916 via openalex
- W2087476228 via openalex
- W2147072925 via openalex
- W2161656900 via openalex
- W2179180919 via openalex
- W2190059341 via openalex
- W2325261753 via openalex
- W2528330046 via openalex
Cited by (3)
- Management of women with endometriosis in the 21st century 2025
- Fertility preservation in women with endometriosis: A retrospective non-Inferiority study comparing Dienogest in the PPOS protocol to antagonist and agonist protocols 2025
- Complications de la chirurgie de l'endométriose pelvienne profonde 2024
Source provenance
- europepmc
- last seen: 2026-11-19T06:13:19.037553+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:33:47.824698+00:00
License: CC0
· commercial use OK